Prime Medicine, Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

2.965

-0.165 (-5.27%)

At close: Feb 21, 2025, 4:00 PM

2.970

+0.005 (0.17%)

After-hours: Feb 21, 2025, 5:28 PM EST

Prime Medicine Employees

Prime Medicine had 234 employees as of December 31, 2023. The number of employees increased by 59 or 33.71% compared to the previous year.

Employees

234

Change (1Y)

59

Growth (1Y)

33.71%

Revenue / Employee

$3,419

Profits / Employee

-$936,962

Market Cap

378.32M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	234	59	33.71%
Dec 31, 2022	175	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	440,000
Johnson & Johnson	131,900
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	72,000

Employee Rankings

PRME News

23 days ago - Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm - PRNewsWire
3 months ago - Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies - Seeking Alpha
3 months ago - Wilson Disease Pipeline Market Research Report 2024: Comprehensive Insights on 5+ Drugs Featuring Vivet Therapeutics, Depymed, Prime Medicine, and Deep Genomics - GlobeNewsWire
3 months ago - Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
4 months ago - Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress - GlobeNewsWire
4 months ago - Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings - GlobeNewsWire
5 months ago - Crude Oil Moves Higher; Prime Medicine Shares Spike Higher - Benzinga
5 months ago - Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline - Benzinga